These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30500834)

  • 1. Human lung tissue provides highly relevant data about efficacy of new anti-asthmatic drugs.
    Danov O; Jiménez Delgado SM; Obernolte H; Seehase S; Dehmel S; Braubach P; Fieguth HG; Matschiner G; Fitzgerald M; Jonigk D; Knauf S; Pfennig O; Warnecke G; Wichmann J; Braun A; Sewald K
    PLoS One; 2018; 13(11):e0207767. PubMed ID: 30500834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAG-EPA resolves lung inflammation in an allergic model of asthma.
    Morin C; Fortin S; Cantin AM; Rousseau É
    Clin Exp Allergy; 2013 Sep; 43(9):1071-82. PubMed ID: 23957343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
    Doucet C; Giron-Michel J; Canonica GW; Azzarone B
    Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory activity of inhaled IL-4 receptor-alpha antisense oligonucleotide in mice.
    Karras JG; Crosby JR; Guha M; Tung D; Miller DA; Gaarde WA; Geary RS; Monia BP; Gregory SA
    Am J Respir Cell Mol Biol; 2007 Mar; 36(3):276-85. PubMed ID: 16990616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvianolic acid B improves airway hyperresponsiveness by inhibiting MUC5AC overproduction associated with Erk1/2/P38 signaling.
    Guan Y; Zhu JP; Shen J; Jia YL; Jin YC; Dong XW; Xie QM
    Eur J Pharmacol; 2018 Apr; 824():30-39. PubMed ID: 29382534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT-6 independently of IL-5 and eotaxin.
    Yang M; Hogan SP; Henry PJ; Matthaei KI; McKenzie AN; Young IG; Rothenberg ME; Foster PS
    Am J Respir Cell Mol Biol; 2001 Oct; 25(4):522-30. PubMed ID: 11694459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulized anti-IL-13 monoclonal antibody Fab' fragment reduces allergen-induced asthma.
    Hacha J; Tomlinson K; Maertens L; Paulissen G; Rocks N; Foidart JM; Noel A; Palframan R; Gueders M; Cataldo DD
    Am J Respir Cell Mol Biol; 2012 Nov; 47(5):709-17. PubMed ID: 22904197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling.
    Yang G; Volk A; Petley T; Emmell E; Giles-Komar J; Shang X; Li J; Das AM; Shealy D; Griswold DE; Li L
    Cytokine; 2004 Dec; 28(6):224-32. PubMed ID: 15566951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity.
    Sharkhuu T; Matthaei KI; Forbes E; Mahalingam S; Hogan SP; Hansbro PM; Foster PS
    Clin Exp Allergy; 2006 Dec; 36(12):1575-83. PubMed ID: 17177681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of periostin, FENO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4/IL-13 antagonist in asthma.
    Agrawal S; Townley RG
    Expert Opin Biol Ther; 2014 Feb; 14(2):165-81. PubMed ID: 24283478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Important roles of CD32 in promoting suppression of IL-4 induced immune responses by a novel anti-IL-4Rα therapeutic antibody.
    Zhao J; Jiang L; Deng L; Xu W; Cao Y; Chen C; Yang Y; Wu H; Huang Y; Zhu Z; Huang H
    MAbs; 2019 Jul; 11(5):837-847. PubMed ID: 30950681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism.
    Pope SM; Brandt EB; Mishra A; Hogan SP; Zimmermann N; Matthaei KI; Foster PS; Rothenberg ME
    J Allergy Clin Immunol; 2001 Oct; 108(4):594-601. PubMed ID: 11590387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma.
    Doucet C; Brouty-Boyé D; Pottin-Clémenceau C; Canonica GW; Jasmin C; Azzarone B
    J Clin Invest; 1998 May; 101(10):2129-39. PubMed ID: 9593769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.
    Kim SH; Hong JH; Lee YC
    Eur J Pharmacol; 2013 Feb; 701(1-3):131-43. PubMed ID: 23201068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of interleukin-13 related biomarkers using peripheral blood mononuclear cells.
    Syed F; Huang CC; Li K; Liu V; Shang T; Amegadzie BY; Griswold DE; Song XY; Li L
    Biomarkers; 2007; 12(4):414-23. PubMed ID: 17564846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geniposide inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma.
    Deng Y; Guan M; Xie X; Yang X; Xiang H; Li H; Zou L; Wei J; Wang D; Deng X
    Int Immunopharmacol; 2013 Nov; 17(3):561-7. PubMed ID: 23859870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xiao-Qing-Long-Tang attenuates allergic airway inflammation and remodeling in repetitive Dermatogoides pteronyssinus challenged chronic asthmatic mice model.
    Wang SD; Lin LJ; Chen CL; Lee SC; Lin CC; Wang JY; Kao ST
    J Ethnopharmacol; 2012 Jul; 142(2):531-8. PubMed ID: 22658987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production.
    Zhu Z; Homer RJ; Wang Z; Chen Q; Geba GP; Wang J; Zhang Y; Elias JA
    J Clin Invest; 1999 Mar; 103(6):779-88. PubMed ID: 10079098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging drugs for asthma.
    Walsh GM
    Expert Opin Emerg Drugs; 2008 Dec; 13(4):643-53. PubMed ID: 19046132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice.
    Wang J; Wu J; Kong L; Nurahmat M; Chen M; Luo Q; Li B; Wu X; Dong J
    J Ethnopharmacol; 2014 May; 154(1):131-47. PubMed ID: 24704667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.